Natural

Frontiers of novel drug targets in disease

  • Chair(s):

    Michael Spedding,
    President, Spedding Research Solutions SAS, Le Vesinet, France

    Professor Yongxiang Zhang,
    Beijing Institute of Pharmacology and Toxicology, Beijing, China

  • Session description:

    The novel drug targets in the therapy for mood disorders
    Professor Jianguo Chen
    Vice President, Huazhong University of Science and Technology, China

    Development of a Novel Allosteric c-RAF Inhibitor Against KRAS-driven Pancreatic Cancer
    Dr Connor Mcleod Blair
    Postdoctoral Research Associate, University of Glasgow, United Kingdom

    Oral communication speaker - to be confirmed in 2023.

    GM1 and its oligosaccharides: brain penetration and novel therapies for Parkinson's and Cystic Fibrosis
    Dr Elena Chiricozzi
    Assistant Professor, University of Milano, Italy

    Pharmacological target identification strategy of active natural products
    Dr Kewu Zeng
    Tenure-Track Assistant Professor, Peking University Health Science Centre, China

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Date

05 Jul 2023

Time

9:45 am - 12:10 pm

Speakers

Leave A Comment

Go to Top